Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00665119Phase 4Completed
Phase 4, randomised, double-blind trial of remifentanil in Respiratory Insufficiency (RI), sponsored by Fondazione Poliambulanza. Primary endpoints: Respiratory Rate/Tidal Volume Ratio and Pressure-Time Product. Started Apr 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00665119.